Archeoptix Biomedical Inc. – Trademark Portfolio

Entity Type: 03

Archeoptix Biomedical Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NIRD and ARCHEOPTIX. The owner is based in Kingston, Ontario.

3B-745 Development Dr.

Kingston, Ontario K7M4W6 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NIRD
NIRD
Registered 2016

Trademark Classifications

Archeoptix Biomedical Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Archeoptix Biomedical Inc. have?

Archeoptix Biomedical Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Archeoptix Biomedical Inc. file in?

Archeoptix Biomedical Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Archeoptix Biomedical Inc.'s most well-known trademarks?

Archeoptix Biomedical Inc.'s registered trademark portfolio includes well-known marks such as NIRD and ARCHEOPTIX. These are among 2 currently registered trademarks in the portfolio.

What is Archeoptix Biomedical Inc.'s trademark registration success rate?

Archeoptix Biomedical Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.